Skip to main content
. 2024 Aug 31;16(8):e68324. doi: 10.7759/cureus.68324

Table 4. Treatment-emergent adverse events (TEAE) (adults) .

References [12,20]

  Adler et al.
  2008 [12] 2013 [20]
  pla LDX pla LDX
Number (%)   30 mg 50 mg 70 mg   PO
Participant 62 119 117 122 79 80
Any Event 36 (58) 90 (76) 90 (77) 102 (84) 41 (51) 62 (78)
Anorexia 0 4 (3) 8 (7) 6 (5) 0 4 (5)
Anxiety 0 5 (4) 7 (6) 9 (7) 0 4 (5)
↓ Appetite 1 (2) 34 (29) 33 (28) 28 (23) 5 (6) 26 (33)
Diarrhea 0 8 (7) 12 (10) 4 (3) 2 (2) 6 (8)
Dry Mouth 2 (3) 25 (21) 29 (25) 38 (31) 6 (8) 25 (32)
Jittery 0 2 (2) 4 (3) 9 (7) 0 10 (13)
Insomnia 3 (5) 23 (19) 20 (17) 26 (21) 3 (4) 10 (13)
Nausea 0 10 (8) 7 (6) 8 (7) 5 (6) 2 (3)
Irritability - - - - 3 (4) 8 (10)
Fatigue - - - - 3 (4) 6 (8)
NPG - - - - 4 (5) 4 (5)
URI - - - - 1 (1) 5 (6)
Heart Rate ↑ - - - - 2 (2) 4 (5)
Weight ↓ - - - - 0 8 (10)
Headache - - - - 2 (2) 20 (25)
Initial Insomnia - - - - 5 (6) 8 (10)
Libido ↓ - - - - 0 4 (5)
Hyperhidrosis - - - - 0 4 (5)